BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 9034723)

  • 1. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
    Martin R
    J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice].
    Tutaj M; Szczepanik M
    Postepy Hig Med Dosw (Online); 2006; 60():571-83. PubMed ID: 17115007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
    J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M; Johnson JM; Tuohy VK
    J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
    J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
    J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
    Ben-Nun A; Mendel I; Bakimer R; Fridkis-Hareli M; Teitelbaum D; Arnon R; Sela M; Kerlero de Rosbo N
    J Neurol; 1996 Apr; 243(4 Suppl 1):S14-22. PubMed ID: 8965116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
    McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
    J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
    Stinissen P; Medaer R; Raus J
    Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
    Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
    Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis.
    Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R
    Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaśkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.